6 - 12 May 2017
These are links to news stories from the last week that may be of interest to people in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts
Statins for SPMS
The next phase of research into statins in secondary progressive MS has been announced. The six year trial will start recruiting in the summer and will involve 1,180 people taking either simvastatin or a placebo at 30 hospitals across the UK.
MS Trust link: Simvastatin trial planned for secondary progressive multiple sclerosis (MS Trust news story - includes link to register interest in taking part in the trial)
Laquinimod trial unsuccessful
A phase III trial looking at whether laquinimod was better than placebo at slowing the time to confirmed disability progression in people with relapsing remitting MS has failed to show any difference. A trial in primary progressive MS continues.
MS Trust link: Laquinimod
Clues to MS five years before onset
Vitamin D and birth month
Polish research found that while there were fewer cases of MS in the autumn compared to the spring, this didn't seem to correlate with a pregnant mother's exposure to sunlight. Previous studies have linked the pattern of birth months with the mother's vitamin D levels during pregnancy
Source: MS News Today
MS Trust link: Vitamin D
Contraceptive safety in MS
A study found oral contraceptives weren't linked to risk of relapses in women with MS. A separate report says most contraceptive methods appear safe for women with MS based on current evidence (the exception being hormonal contraceptives in women with prolonged immobility).
Source: National MS Society (USA)
MS Trust link: Contraception